Find Support on Your Journey
Latest News
September 15, 2024
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
New England Journal of Medicine, Ahead of Print.
September 15, 2024
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer
New England Journal of Medicine, Ahead of Print.
September 15, 2024
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
New England Journal of Medicine, Volume 391, Issue 19, November 14, 2024.
September 15, 2024
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
New England Journal of Medicine, Ahead of Print.
September 15, 2024
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
New England Journal of Medicine, Ahead of Print.
Looking for a Clinical Trial?
As of November 12, 2024
3036 Breast Cancer Clinical Trials are now recruiting
2921 Lung Cancer Clinical Trials are now recruiting
1998 Colorectal Cancer Clinical Trials are now recruiting
1382 Prostate Cancer Clinical Trials are now recruiting
1193 Pancreatic Cancer Clinical Trials are now recruiting
Source: clinicaltrials.gov